Philips Introduces AI-Enabled Diagnostic Imaging and Treatment Innovations to Help Improve Patient Care at #ECR2024

PhilipsRoyal Philips, a global leader in health technology, announced it will introduce its latest differentiating, AI-enabled innovations to improve patient care at the European Congress of Radiology (ECR) annual meeting in Vienna. By leveraging AI, these new technologies can help healthcare professionals make more accurate diagnoses, streamline workflows, and ultimately improve patient outcomes. ECR attendees will experience how Philips' innovative platforms and game-changing software enable healthcare providers to focus on what matters most - caring for patients.

Join Philips at The Blue Level at #ECR2024

Philips continues its strong partnership with the European Society of Radiology (ESR) at #ECR2024 where the company is once again expected to attract thousands of attendees with its patient-centric innovations. On Level 2 (The Blue Level), Philips will spotlight innovations across CT, MR, Diagnostic X-ray, Ultrasound, Image Guided Therapy, and Enterprise Informatics, designed to offer outstanding image quality and increase speed and productivity to provide healthcare professionals with the tools they need to deliver exceptional care.

"At this year’s ECR, the focus is ‘Next Generation Radiology’ where innovation will be on all our minds. Significant improvements and advances in speed and precision enabled by AI will be demonstrated by health tech leaders like Philips, all in the service of improving patient care," said Prof. Carlo Catalano, President of the European Society of Radiology (ESR) and the European Congress of Radiology (ECR).

"At #ECR2024, we’ll demonstrate how our AI-enabled solutions can help radiologists address some their most pressing challenges, including cost of care, staff shortages, and improving patient outcomes, while at the same time reducing environmental impact," said Atul Gupta, MD, Chief Medical Officer in Precision Diagnosis and Image Guided Therapy at Philips, and a diagnostic and interventional radiologist. "One stand-out example is Philips’ leadership in helium-free MR operations. With more than 1,000 systems installed globally, the Philips BlueSeal magnet is the industry's first 1.5T fully sealed magnet, relieving health systems from helium-related complications. We have now brought our innovation in helium-free MR to a mobile truck."

Europe's first mobile MRI system with helium-free operations at #ECR2024

The first BlueSeal MR mobile unit [1] developed in Europe for Denmark-based Agito Medical Imaging will debut at #ECR2024. MRI scanners equipped with Philips’ BlueSeal magnet technology have saved more than 1.9 million liters of helium since 2018 [2]. The extension of this breakthrough technology in a mobile unit means Philips will be able to expand quality access to MRI exams for more patients in more places across Europe, in a more sustainable way with helium-free operations.

Care means the world

Underpinning Philips' innovations is the company’s commitment to driving sustainable healthcare, developing solutions to help care for patients and the planet with the same urgency and attention. ECR attendees will experience the Philips ‘Care means the world’ campaign, reinforcing that improving human health and environmental health need to go hand in hand. From the development of energy-efficient technologies to better use and re-use of products and materials, visitors to the Philips sustainability station at #ECR2024 will see how Philips is driving systematic change to lower the environmental footprint of healthcare for greater societal benefit, and stronger financial value for health systems.

Join Philips in person at the Blue Level at #ECR2024, or virtually via the Philips interactive online radiology experience.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...